Centaurus Financial’s Fresenius Medical Care FMS Stock Holding History

Centaurus Financial’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-8	Closed	–	–	1064
2018 Q2	$0	Buy	+8	New	+$406	﹤0.01%	2283

Other funds holding FMS

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Group Covington, Kentucky $2.39B AUM 27.81% 1-Year Est. Return

Centaurus Financial's FMS Position: Q3 2018 in Review

Centaurus Financial sold out of Fresenius Medical Care (FMS) in Q3 2018, closing a stake of 8 shares.

Centaurus Financial first reported a position in FMS in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 223 funds tracked by Wall St. Rank hold FMS as of Q3 2018.

Centaurus Financial reported no remaining Fresenius Medical Care position as of Q3 2018 after selling out during the quarter.
Centaurus Financial sold 8 Fresenius Medical Care shares in Q3 2018.
Centaurus Financial first reported a position in Fresenius Medical Care in Q2 2018 and held it in 1 quarter.
Centaurus Financial's Fresenius Medical Care position peaked at $0 in Q2 2018.
223 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.